AbCellera Biologics Inc. Common Shares (ABCL) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ABCL. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 115 institutions reported holding ABCL, with 56.1 million shares worth $808.2 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Capital Group | 13,579,116 | $198M | DECREASED |
| TD Waterhouse Canada | 9,222,005 | $128M | DECREASED |
| Marshall Wace | 8,958,273 | $131M | INCREASED |
| BlackRock | 5,660,637 | $83M | INCREASED |
| Arrowstreet Capital, Limited Partnership | 2,013,668 | $29M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Andrew Booth (Chief Financial Officer) | BUY | 8,600 | $97K | 2026-11-13 |
| Thermopylae Holdings Ltd. (10% Owner) | GIFT | 125,000 | 2026-11-13 | |
| Andrew Booth (Chief Financial Officer) | EXERCISE | 50,000 | $16K | 2026-11-13 |
| Andrew Booth (Chief Financial Officer) | GIFT | 50,000 | 2026-11-13 | |
| Andrew Booth (Chief Financial Officer) | EXERCISE | 50,000 | $16K | 2026-11-13 |
Full institutional holdings, insider history, and congressional trades for AbCellera Biologics Inc. Common Shares on SentiSense.